Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma.
Nokin MJ, Darbo E, Travert C, Drogat B, Lacouture A, San José S, Cabrera N, Turcq B, Prouzet-Mauleon V, Falcone M, Villanueva A, Wang H, Herfs M, Mosteiro M, Jänne PA, Pujol JL, Maraver A, Barbacid M, Nadal E, Santamaría D, Ambrogio C.
Nokin MJ, et al.
JCI Insight. 2020 Aug 6;5(15):e137869. doi: 10.1172/jci.insight.137869.
JCI Insight. 2020.
PMID: 32759499
Free PMC article.